The KOSHINÉ Blog: Hair Wellness Starts Here – KOSHINE
Discover the Next Generation of Hair Regrowth Solutions.

The KOSHINÉ Blog: Hair Wellness Starts Here

  • Awaken Your Inner Glow — Koshine Anti-Pigment Serum

    Every drop tells a story of renewal, balance, and quiet confidence.When applied, it feels weightless — soft, silky, and pure — yet it helps the skin appear more radiant. Koshine Anti-Pigment Serum is formulated to help brighten dull skin and...

  • From Hair Loss Worries to Fuller, Healthier Hair: The KX-826 Innovation Journey

    Hair thinning and hair loss are common concerns today. A receding hairline and thinning hair not only affect appearance but can also impact confidence and well-being.While many “anti-hair loss” and “hair growth” products exist, most only provide temporary effects and...

  • KX-826 Androgen receptor antagonist

    KX-826 is a topical androgen receptor (AR) antagonist, the world's first AR antagonist for the treatment of alopecia areata to enter registrational Phase III clinical trials.KX-826 works by competing with dihydrotestosterone (DHT) for binding to the AR, thereby locally blocking...

  • Long-Term Safety Phase III Clinical Trial Of KX-826 For The Treatment Of AGA Reached Primary Endpoint

    Suzhou, 20 March, 2025-Kintor Pharmaceutical Limited (“Kintor Pharma”, HKEX: 9939), announced that the long-term safety phase III clinical trial of its in-house developed and potential first-in-class KX-826 tincture for the treatment of AGA has obtained top-line results. Results indicated that...

  • Official Commencement Of Global Sales Business Of Whitening And Freckle-Removing Functional Cosmetic Raw Material KT-939

    Suzhou, 8 May, 2025-Kintor Pharmaceutical Limited (“Kintor Pharma”, HKEX: 9939), announced that the global sales business of its self-developed KT-939, a functional raw material for whitening and freckle-removing cosmetics, has officially commenced. The Company has recently completed its first sales...

  • Receipt Of JNCI Designation For KT-939

    Suzhou, 25 June, 2025-Kintor Pharmaceutical Limited (“Kintor Pharma”, HKEX: 9939), announced that its in-house developed KT-939 has passed the review of the Japanese Nomenclature Cosmetic Ingredient (the “JNCI”) by the Japanese Cosmetic Industry Committee. The officially assigned name is メチルオキセタンカルバミドチアゾリルレゾルシノ一ル....